gemfibrozil has been researched along with Compensatory Hyperinsulinemia in 1 studies
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the effects of gemfibrozil on glucose and fatty acid metabolism in subjects with mild endogenous hypertriglyceridemia." | 9.08 | Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia. ( Knudsen, P; Sane, T; Taskinen, MR; Vuorinen-Markkola, H; Yki-Järvinen, H, 1995) |
| "We studied the effects of gemfibrozil on glucose and fatty acid metabolism in subjects with mild endogenous hypertriglyceridemia." | 5.08 | Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia. ( Knudsen, P; Sane, T; Taskinen, MR; Vuorinen-Markkola, H; Yki-Järvinen, H, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sane, T | 1 |
| Knudsen, P | 1 |
| Vuorinen-Markkola, H | 1 |
| Yki-Järvinen, H | 1 |
| Taskinen, MR | 1 |
1 trial available for gemfibrozil and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia.
Topics: Analysis of Variance; Apolipoprotein A-II; Blood Glucose; Cholesterol; Circadian Rhythm; Double-Blin | 1995 |